Phase I trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery
$206,138N01FY2020CANIH
Northwestern University At Chicago, Evanston IL
Investigators
Abstract
The proposed clinical trial will address whether daily application of endoxifene gel in escalating dose cohorts is tolerable and safe compared to placebo gel.
View original record on NIH RePORTER →